Charles River Laboratories (CRL) Tops Q2 EPS by 28c; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- S&P 500 ends down; Apple dips ahead of quarterly report
- Apple beats quarterly estimates for profit and revenue
- Marvell agrees $115 billion all-stock deal to buy Lumentum
- Oil drops 7% as Iran signals openness to peace talks
- Palantir raises 2026 revenue outlook after quarterly revenue nearly doubles on AI
| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 338.54 -20.87 (5.81%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $359.41 | 52 Week High | $89.18 | |||
| Open | $368.42 | 52 Week Low | $65.70 | |||
| Day High | $369.61 | P/E | 157.46 | |||
| Day Low | $337.37 | EPS | $2.15 | |||
| Volume | 1,620,554 | |||||
